Besides, Noor Momin and colleagues reported two fusion proteins of collagen-binding protein lumican with IL-2 and IL-12, which represented impressive anti-tumor efficacy when administrated individually or jointly in multiple mouse models (65). Here, LUM is linked to neoplasm.